Who is sponsoring NCT04505345?

NCT04505345 is sponsored by Universidade Lusófona de Humanidades e Tecnologias.

What drugs are being tested in NCT04505345?

Interventions in NCT04505345: Cognitive training using the Systemic Lisbon Battery, Treatment-as-usual.

What condition does NCT04505345 study?

NCT04505345 studies Cognitive Function, Feasibility.

Is NCT04505345 still recruiting?

NCT04505345 is currently status unknown. Last updated 11 May 2023.

Last reviewed 2023-05-11 · How we verify

NCT04505345

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Virtual Reality Cognitive Training in Alcohol Use Disorder

Status unknown NA Last updated 11 May 2023

What this trial tests

NA trial testing Cognitive training using the Systemic Lisbon Battery in Cognitive Function in 41 participants. Status unknown.

Timeline

30 September 2017

Primary endpoint
30 September 2018

30 July 2024

Quick facts

Lead sponsor	Universidade Lusófona de Humanidades e Tecnologias
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	41
Start date	30 September 2017
Primary completion	30 September 2018
Estimated completion	30 July 2024
Sites	1 location across Portugal

Drugs / interventions tested

Cognitive training using the Systemic Lisbon Battery
Treatment-as-usual

Conditions studied

Cognitive Function — all drugs for Cognitive Function →
Feasibility — all drugs for Feasibility →

Sponsor

Universidade Lusófona de Humanidades e Tecnologias

Who can join

18 and older, any sex, with Cognitive Function or Feasibility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to test the feasibility of using exercises in virtual reality for cognitive training of patients with alcohol use disorder undergoing residential treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Virtual Reality Cognitive Training Among Individuals With Alcohol Use Disorder Undergoing Residential Treatment: Pilot Randomized Controlled Trial.
Gamito P, Oliveira J, Matias M, Cunha E, et al · · 2021 · cited 19× · PMID 33512329 · DOI 10.2196/18482

Verify or expand the search:

Other recruiting trials for Cognitive Function

Currently open trials in the same condition.

NCT07586696 — Effects of Exercise Board Games on Cognitive Function in Older Adults · NA · active not recruiting
NCT07245784 — Radicle Clarity™ RBB: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Hea · NA · recruiting
NCT07103343 — MOVI-OLE! [Open Learning Environments] · NA · active not recruiting
NCT07312435 — B-vitamins and Omega-3 Fatty Acids and Biomarkers of Brain Atrophy. · NA · recruiting
NCT07139210 — EFFECT OF PERCEPTUAL-MOTOR TRAINING ON COGNITIVE FUNCTIONS, MOTOR ABILITIES AND QUALITY OF LIFE IN CHILDREN WITH ATTENTI · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04505345 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidade Lusófona de Humanidades e Tecnologias
Last refreshed: 11 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04505345.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing